Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)

NCT02913612 is registered in ClinicalTrials.gov with Kanecia Obie Zimmerman as lead sponsor.

NCT NCT02913612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02913612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety, and Pharmacokinetics of Timolol in Infants With Infantile Hemangioma (IH)
Lead sponsor
Kanecia Obie Zimmerman
Phase
Phase 2
Overall status
Completed
Start date
May 5, 2017
Completion date
October 20, 2020
Enrollment
105 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

infantile hemangioma